Dr. Reddy’s Laboratories Ltd. (DRREDDY): Dr. Reddy’s Laboratories Share Price rises 2.07% today

Published: 21 September 2026 at 9:19:50 AM IST

Dr. Reddy’s Laboratories Share Price moved higher today to Rs 1,195.35, a gain of 2.07% from the previous close of Rs 1,171.10, while the company’s market capitalisation stood at Rs 97,749.41 Cr. The stock opened at Rs 1,186.20, matched the day’s high of Rs 1,195.35 and held the same low at Rs 1,186.20, which confirms a narrow intraday range. The supplied data confirms a same-day price rise, but it does not establish a company-specific catalyst. For readers tracking Dr. Reddy’s Laboratories Share Price Today, the most useful follow-up is to watch whether the move remains consistent with valuation, sector comparison and the next set of company disclosures. Univest will continue to track this Dr. Reddy’s Laboratories Stock News flow in a structured format.

In market terms, the move places Dr. Reddy’s Laboratories among the stocks rising today in the Indian Stock Market conversation, though the supplied data itself only confirms the price action and turnover of Rs 0.23 Cr. Univest highlights the event because it adds a fresh share price update for a Healthcare name with a large market cap and meaningful sector relevance.

Dr. Reddy’s Laboratories Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 1,195.35
Previous Close	Rs 1,171.1
Today's Move	Rs 24.25 (+2.07%)
Open	Rs 1,186.2
High	Rs 1,195.35
Low	Rs 1,186.2
Turnover	Rs 0.23 crore
Market Capitalisation	Rs 97,749.41 crore
Market Cap Category	Large Cap

Dr. Reddy's Laboratories Ltd. (DRREDDY) rose to Rs 1,195.35 from the previous close of Rs 1,171.1, a move of Rs 24.25 or 2.07%. The stock opened at Rs 1,186.2, reached a high of Rs 1,195.35, recorded a low of Rs 1,186.2.

Dr. Reddy’s Laboratories Share Price today rose by Rs 24.25, or 2.07%, with the session’s opening price at Rs 1,186.20, the low at Rs 1,186.20 and the high at Rs 1,195.35. The stock closed at the day’s high, and the move was recorded alongside turnover of Rs 0.23 Cr. The data confirms a positive price rise session, but it does not establish a company-specific trigger. For investors scanning Dr. Reddy’s Laboratories Share Price Live or Dr. Reddy’s Laboratories Stock Gaining Today queries, the key point is the precise intraday range and the fact that the stock ended at the highest printed level of the day.

Dr. Reddy's Laboratories Ltd. (DRREDDY) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 97,749.41 crore
P/E Ratio	30.34x
P/B Ratio	2.56x
ROE	11.69%
ROCE	13.75%
EPS	Rs 38.6
Book Value Per Share	Rs 457.39
Dividend Yield	0.68%

Dr. Reddy's Laboratories Ltd. (DRREDDY) fundamental metrics show P/E 30.34x, P/B 2.56x, ROE 11.69%, ROCE 13.75%. These figures provide context only and are not a buy or sell signal.

Dr. Reddy’s Laboratories Ltd. has a market capitalisation of Rs 97749.41 crore and falls in the Large Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 30.34x, P/B at 2.56x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 11.69% and ROCE of 13.75%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 38.6, book value per share of Rs 457.39, dividend yield of 0.68%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 32.87x, median ROE of 11.7%, median ROCE of 13.46%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Company P/E Ratio	30.34x
Benchmark Median P/E	32.87x
Benchmark Average P/E	48.77x
Benchmark P/E Range	3.4x to 683.5x
Company P/B Ratio	2.56x
Benchmark Median P/B	3.08x
Company ROE	11.69%
Benchmark Median ROE	11.7%
Company ROCE	13.75%
Benchmark Median ROCE	13.46%
Company Market Capitalisation	Rs 97,749.41 crore
Benchmark Median Market Cap	Rs 701.78 crore

Dr. Reddy's Laboratories Ltd. (DRREDDY) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.

Dr. Reddy's Laboratories Ltd. (DRREDDY) has a P/E ratio of 30.34x, which is below the benchmark median of 32.87x, a difference of -7.7%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Dr. Reddy's Laboratories Ltd. (DRREDDY) has a ROE of 11.69%, which is below the benchmark median of 11.7%, a difference of -0.09%. Dr. Reddy's Laboratories Ltd. (DRREDDY) has a ROCE of 13.75%, which is above the benchmark median of 13.46%, a difference of +2.15%.

Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Sun Pharmaceutical Industries Ltd.	SUNPHARMA	4,40,397.93	36.41	5.09	14.85	19.11
Divi's Laboratories Ltd.	DIVISLAB	2,48,664.42	85.01	14.08	16.19	21.51
Torrent Pharmaceuticals Ltd.	TORNTPHARM	1,82,738.23	83.79	20.36	26.76	19.27
Zydus Lifesciences Ltd.	ZYDUSLIFE	1,15,012.19	25.48	4.27	19.69	21.39
Cipla Ltd.	CIPLA	1,10,793.75	32.87	3.15	11.83	16

Dr. Reddy's Laboratories Ltd. (DRREDDY) has a P/E ratio of 30.34x compared with the displayed peer median of 36.41x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 11.69% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 13.75% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Dr. Reddy's Laboratories Ltd. (DRREDDY) has a market capitalisation of Rs 97,749.41 crore. Among the 5 peers shown, 5 have a larger market capitalisation.

Why Investors Are Watching Dr. Reddy’s Laboratories

• Dr. Reddy’s Laboratories Share Price rose 2.07% today to Rs 1,195.35.
• The day’s range stayed tight, with Rs 1,186.20 as both the open and the low, and Rs 1,195.35 as the high.
• Market capitalisation stood at Rs 97,749.41 Cr, which places the company within a large listed healthcare universe.
• P/E of 30.34 and P/B of 2.56 can be compared with the same-industry benchmark and peer set.
• ROE of 11.69%, ROCE of 13.75%, EPS of Rs 38.60, book value of Rs 457.39 and dividend yield of 0.68% add financial context.

About Dr. Reddy’s Laboratories

Dr. Reddy’s Laboratories is a Pharmaceuticals & Drugs company in the Healthcare sector. The business is tracked by investors because it operates in a regulated pharmaceutical segment where earnings quality, return ratios and valuation often matter together. On the supplied data, the company’s profile is best understood through its market capitalisation, profitability metrics and industry position inside a large same-industry benchmark. Dr. Reddy’s Laboratories Share Price therefore reflects not only a one-day market move, but also how the stock is judged against established pharmaceutical peers. Univest covers Dr. Reddy’s Laboratories Stock News and Dr. Reddy’s Laboratories Latest News with the aim of keeping the analysis factual, current and easy to compare with the wider Indian Stock Market. Readers following Dr. Reddy’s Laboratories Share News can use the company’s earnings, book value and dividend data as part of a broader financial analysis view.

Track Dr. Reddy’s Laboratories Share Price on Univest

Use Dr. Reddy's Laboratories Ltd. (DRREDDY) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.

Track Dr. Reddy’s Laboratories Share Price on Univest for live share price updates, fundamental ratios, shareholding pattern, 52-week levels and market insights. Univest also helps readers review sector context, peer comparison and the stock’s latest news flow in one place.

Frequently Asked Questions

Why did Dr. Reddy's Laboratories Share Price rise today?

Ans. The supplied data confirms that Dr. Reddy's Laboratories Share Price rose 2.07% today to Rs 1,195.35. It does not establish a company-specific catalyst, so the event should be read as verified price action only.

What is Dr. Reddy's Laboratories Share Price Today?

Ans. Dr. Reddy's Laboratories Share Price Today is Rs 1,195.35. The stock moved up Rs 24.25 from the previous close of Rs 1,171.10 and finished at the day’s high. The previous close was Rs 1,171.1.

What is the market cap of Dr. Reddy's Laboratories?

Ans. Dr. Reddy's Laboratories has a market capitalisation of Rs 97,749.41 Cr. Market cap shows company size in the listed market, and here it places the stock within a large healthcare universe.

How is Dr. Reddy's Laboratories valued on P/E and P/B?

Ans. Dr. Reddy's Laboratories trades at a P/E of 30.34 and a P/B of 2.56. Both are below the same-industry median, which gives the current valuation useful benchmark context. The company trades at a P/E ratio of 30.34x.

What do ROE, ROCE and EPS show for Dr. Reddy's Laboratories?

Ans. ROE is 11.69% and ROCE is 13.75%, while EPS stands at Rs 38.60. Together, these metrics show earnings and capital efficiency in a factual way, without making any forecast. ROE stands at 11.69%.

How does Dr. Reddy's Laboratories compare with healthcare peers?

Ans. Dr. Reddy's Laboratories has a lower P/E than Divi's Laboratories and Torrent Pharmaceuticals, but its ROE and ROCE trail several peers. The comparison helps readers place Dr. Reddy's Laboratories Share Price in context.

What is the dividend yield of Dr. Reddy's Laboratories?

Ans. Dr. Reddy's Laboratories has a dividend yield of 0.68%. Dividend yield is historical and current data tied to the share price, so it should be read alongside earnings, book value and valuation.